Detalles de la búsqueda
1.
Effectiveness and safety of empagliflozin in routine care patients: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study.
Diabetes Obes Metab
; 24(3): 442-454, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34729891
2.
Confirming diagnoses of acute pancreatitis with commonly available electronic data.
Pharmacoepidemiol Drug Saf
; 30(3): 313-319, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33368819
3.
Health Care Costs by Type of Expenditure across eGFR Stages among Patients with and without Diabetes, Cardiovascular Disease, and Heart Failure.
J Am Soc Nephrol
; 31(7): 1594-1601, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32487562
4.
Empagliflozin and the Risk of Heart Failure Hospitalization in Routine Clinical Care.
Circulation
; 139(25): 2822-2830, 2019 06 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-30955357
5.
Incidence of lower extremity amputations among patients with type 1 and type 2 diabetes in the United States from 2010 to 2014.
Diabetes Obes Metab
; 22(7): 1132-1140, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32090430
6.
Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes.
BMC Nephrol
; 21(1): 167, 2020 05 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32380961
7.
Correction to: Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes.
BMC Nephrol
; 21(1): 200, 2020 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-32466752
8.
Cardiovascular safety of linagliptin compared with other oral glucose-lowering agents in patients with type 2 diabetes: A sequential monitoring programme in routine care.
Diabetes Obes Metab
; 21(8): 1824-1836, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30941884
9.
Development and validation of algorithms to identify newly diagnosed type 1 and type 2 diabetes in pediatric population using electronic medical records and claims data.
Pharmacoepidemiol Drug Saf
; 28(2): 234-243, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30677205
10.
Safety of non-insulin glucose-lowering drugs in pregnant women with pre-gestational diabetes: A cohort study.
Diabetes Obes Metab
; 20(7): 1642-1651, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29498473
11.
Claims-based studies of oral glucose-lowering medications can achieve balance in critical clinical variables only observed in electronic health records.
Diabetes Obes Metab
; 20(4): 974-984, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29206336
12.
Real world management of pregestational diabetes not achieving glycemic control for many patients in the UK.
Pharmacoepidemiol Drug Saf
; 27(8): 940-948, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29740916
13.
Identification of impaired fasting glucose, healthcare utilization and progression to diabetes in the UK using the Clinical Practice Research Datalink (CPRD).
Pharmacoepidemiol Drug Saf
; 25(12): 1375-1386, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27193175
14.
Sensitivity analysis of methods for active surveillance of acute myocardial infarction using electronic databases.
Epidemiology
; 26(1): 130-2, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25390030
15.
Assessing the impact of propensity score estimation and implementation on covariate balance and confounding control within and across important subgroups in comparative effectiveness research.
Med Care
; 52(3): 280-7, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-24374422
16.
Patients With Stricturing or Penetrating Crohn's Disease Phenotypes Report High Disease Burden and Treatment Needs.
Inflamm Bowel Dis
; 29(6): 914-922, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35880838
17.
Economic burden related to fistulas or strictures among commercially insured patients with Crohn's disease in the United States.
J Manag Care Spec Pharm
; 29(4): 400-408, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36989446
18.
Cardiovascular and renal effectiveness of empagliflozin in routine care in East Asia: Results from the EMPRISE East Asia study.
Endocrinol Diabetes Metab
; 4(1): e00183, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33532619
19.
The EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study programme: Design and exposure accrual for an evaluation of empagliflozin in routine clinical care.
Endocrinol Diabetes Metab
; 3(1): e00103, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31922030
20.
Comorbidities and cause-specific outcomes in heart failure across the ejection fraction spectrum: A blueprint for clinical trial design.
Int J Cardiol
; 313: 76-82, 2020 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32360702